LM Aledort
- Hematology top 0.2%
- Hemophilia Treatment and Research 14
- Platelet Disorders and Treatments 10
- Blood groups and transfusion 8
- Chronic Myeloid Leukemia Treatments 5
- Nephrology top 2%
- Hepatology top 2%
- Hepatitis C virus research 4
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 7
-
- Cancer-related gene regulation 3
-
- Virology and Viral Diseases 2
- Cited by
- HematologyNephrologyHepatology
- Partner nations
- United StatesItalyCanada
In The Last Decade
LM Aledort
25 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Hematology 2.4k
- Nephrology 365
- Hepatology 372
- Genetics 380
- Pathology and Forensic Medicine 451
Countries citing papers authored by LM Aledort
This map shows the geographic impact of LM Aledort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LM Aledort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LM Aledort more than expected).
Fields of papers citing papers by LM Aledort
This network shows the impact of papers produced by LM Aledort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LM Aledort. The network helps show where LM Aledort may publish in the future.
Co-authorship network
The 25 scholars most cited alongside LM Aledort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 22 | |
| 2 | 1998 | 15 | |
| 3 | Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]breakdown → | 1996 | 1115 |
| 4 | 1995 | 27 | |
| 5 | 1995 | 121 | |
| 6 | Impact of HIV and its treatment on chronic hepatitis C in hemophiliacs | 1994 | 1 |
| 7 | 1993 | 45 | |
| 8 | 1993 | 58 | |
| 9 | 1991 | 240 | |
| 10 | 1991 | 153 | |
| 11 | 1989 | 7 | |
| 12 | 1988 | 2 | |
| 13 | 1985 | 117 | |
| 14 | 1985 | 30 | |
| 15 | 1985 | 3 | |
| 16 | 1985 | 23 | |
| 17 | 1983 | 2 | |
| 18 | 1983 | 93 | |
| 19 | 1983 | 2 | |
| 20 | 1978 | 12 |
About LM Aledort
LM Aledort is a scholar working on Hematology, Genetics, Hepatology, Biochemistry and Pathology and Forensic Medicine, having authored 28 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (10 papers), Blood groups and transfusion (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Hepatitis C virus research (4 papers), Cancer-related gene regulation (3 papers) and Virology and Viral Diseases (2 papers). The work is most often cited by research in Hematology (2.4k citations), Nephrology (365 citations), Hepatology (372 citations), Genetics (380 citations) and Pathology and Forensic Medicine (451 citations). LM Aledort has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include V. Blanchette, JB Bussel, Woolf Sh, Robert McMillan, JG Kelton, Indira Warrier, JN George, Raskob Ge, DB Cines and M. Elaine Eyster. Their work appears in journals such as Blood, Transfusion, Haemophilia, Annals of Internal Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.